Abstract
Hearing loss as a side effect in patients with head and neck malignancies with chemoradiation is frequently ignored. Its effects on auditory functions are less studied and there are studies done on animals which are less reliable. The present study was undertaken to identify the type of hearing loss and also to quantify the degree of hearing loss in these patients. A prospective, descriptive study was undertaken in histologically proven head and neck cancer patients treated with cobalt 60 teletherapy who received a dose of 60–66 Grays (Gy) over a period of 6–7 weeks with concurrent Cisplatin 30 mg/m2 once weekly for 6 weeks. The study included 40 patients (80 ears) undergoing chemoradiation. A baseline pure tone audiometry and impedance audiometry was performed in all the cases prior to the therapy and the same was repeated immediately after the completion of treatment, at 8 and 16 weeks. The changes in pure tone level thresholds and impedance from baseline were correlated with the dose of radiation and chemotherapy. Sensori neural hearing loss (SNHL) and conductive hearing loss was observed in 82.5 and 17.5 % respectively. At the end of 16 weeks, SNHL was found in 27.5, 72.5 and 82.5 % at 2, 4 and 8 kHz respectively. In addition, Eustachian tube dysfunction and Otitis media with effusion was observed in 10 and 7.5 % of patients respectively which lead to conductive hearing loss. Further, it was noted that SNHL in patients with high risk site malignancy (81.8 %) was alarmingly higher compared with low risk site malignancy (18.1 %). The hearing loss at 62, 64 and 66 Gy in comparison to 60 Gy was statistically significant. Hearing loss, specially SNHL was the predominant finding in our study with >80 % of patients showing the inner ear damage due to irradiation of head and neck malignancies. Although, all the frequencies like 2, 4 and 8 kHz were significantly affected, SNHL was more marked in the latter two frequencies. Nearly, 90 % of the patients who had SNHL belonged to high risk site category of head and neck malignancies. Increasing the radiation dosage was directly proportional to the degree of hearing loss with the dose more than 60 Gy causing significant injury to the middle and inner ear.
Similar content being viewed by others
References
Mishra A, Meherotra R (2014) Head and neck cancer: global burden and regional trends in India. Asian Pac J Cancer Prev 15(2):537–550
Tan PX, Du SS, Ren C, Yao QW, Yuan YW (2013) Radiation-induced Cochlea hair cell death: mechanisms and protection. Asian Pac J Cancer Prev 14(10):5631–5635
Grau C, Overgaard J (1996) Postirradiation sensorineural hearing loss: a common but ignored late radiation complication. Int J Radiat Oncol Biol Phys 36(2):515–517
Raaijmakers E, Engelen AM (2002) Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature. Radiother Oncol 65:1–7
Kwong DLW, Wei WI, Sham JST, Ho WK, Yuen PW, Chua DTT et al (1996) Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment. Int J Radiat Oncol Biol Phys 36:281–289
Petsuksiri J, Sermsree A, Thephamongkhol K, Keskool P, Thongyai K, Chansilp Y et al (2011) Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients. Radiat Oncol 6:19
Chan SH, Ng WT, Kam KL, Lee MCH, Choi CW, Yau TK et al (2009) Sensorineural hearing loss after treatment of nasopharyngeal Carcinoma: a longitudinal analysis. Int J Radiat Oncol Biol Phys 73(5):1335–1342
Carls JL, Mendenhall WM, Morris CG (2002) External auditory canal stenosis after radiation therapy. Laryngoscope 112:1975–1978
Zuura CL, Simisb YJW, Verkaikc RS, Schornageld JH, Balmef AJM, Dreschlerb WA et al (2008) Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer. Radiother Oncol 89:38–43
Herrmann F, Dorr W, Muller R, Herrmann T (2006) A Prospective Study On Radiation-Induced Changes in hearing Function. Int Radiat Oncol Biol Phys 65(5):1338–1344
Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR (2005) Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 61(5):1393–1402
Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM (2007) Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 67(2):469–479
Goel HC, Laad P, Naik A (2013) The study of auditory effects after concomitant radiotherapy and chemotherapy in patients with head and neck cancer. Indian J Otol 19:136–139
Delľ Aringa AHB, Issac ML, Arruda GV, Carolina M, Delľ Aringa AR, Simoes JL (2009) Audiological findings in patients treated with radio- and concomitant chemotherapy for head and neck tumors. Radiat Oncol 4:53
Young YH, Chenh PW, Ko JY (1997) A 10-year longitudinal study of tubal function in patients with nasopharyngeal carcinoma after irradiation. Arch Otolaryngol Head Neck Surg 123:945–948
Oh YT, Kim CH, Choi JH (2004) Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma. Radiother Oncol 72:79–82
Ho WK, Wei WI, Kwong DL (1999) Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: a prospective study. Head Neck 21:547–553
Honore HB, Bentzen SM, Moller K, Grau C (2002) Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. Radiother Oncol 65:9–16
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jain, A., Banerjee, P.K. & Manjunath, D. Effects of Chemoradiation on Hearing in Patients with Head and Neck Malignancies: Experience at a Tertiary Referral Care Hospital. Indian J Otolaryngol Head Neck Surg 68, 456–461 (2016). https://doi.org/10.1007/s12070-016-0985-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-016-0985-1